Lutein, Zeaxanthin, and Fish Oil for Cognitive Functioning
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn the impact of lutein, zeaxanthin, and fish oil (LZF) supplementation in healthy adults. The main question it aims to answer is: Will supplementation with LZF improve macular pigment optical density (MPOD), cognitive performance and bone mass compared to controls after six months? Subjects with an MPOD \<.43 will significantly improve MPOD after 6-months of LZF supplementation. Consuming a LZFO supplement for 6-months will improve visual cognitive performance. Consuming a LZFO supplement for 6-months will improve bone density. Participants will be asked to take either a LZF supplement or placebo daily for 6 months.
Will I have to stop taking my current medications?
The trial requires that you do not take neuroactive medications, such as Ritalin, Adderall, or antidepressants, to participate. If you are on these medications, you would need to stop taking them to join the trial.
What evidence supports the effectiveness of the treatment Lutein, Zeaxanthin, and Fish Oil Supplement for cognitive functioning?
Is the combination of Lutein, Zeaxanthin, and Fish Oil safe for humans?
How does the Lutein, Zeaxanthin, and Fish Oil Supplement treatment differ from other treatments for cognitive functioning?
This treatment is unique because it combines lutein and zeaxanthin, which are carotenoids that accumulate in the brain and have been linked to improved cognitive function, with fish oil, known for its omega-3 fatty acids that support brain health. Unlike other treatments, this combination targets cognitive function through both antioxidant properties and support for brain cell membranes.12367
Research Team
Karen M Beathard, PhD
Principal Investigator
Texas A&M University
Eligibility Criteria
This trial is for healthy adults interested in whether taking supplements of lutein, zeaxanthin, and fish oil (LZF) can improve eye health, brain function, and bone density. Specific eligibility criteria are not provided but typically would include age range and general health status.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a LZF supplement or placebo daily for 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Lutein, Zeaxanthin, and Fish Oil Supplement
Lutein, Zeaxanthin, and Fish Oil Supplement is already approved in United States, European Union for the following indications:
- Dietary Supplement for Eye Health
- Supports Macular Health
- Food Supplement for Eye Health
- Contributes to Normal Vision
Find a Clinic Near You
Who Is Running the Clinical Trial?
Texas A&M University
Lead Sponsor
Allen Foundation Inc.
Collaborator